Board of Directors

Abe Schwartz
CHAIRMAN
Abe Schwartz is the founder and president of Schwartz Technologies Corporation and has been an advisor to Covalon Technologies Ltd. since March 7, 2008. Mr. Schwartz has been actively building and managing companies, from start-up to maturity since his first start-up, Polaris Technology Corporation, a computer software firm which he founded in 1977. In 1993, Mr. Schwartz co-founded The Workflow Automation Corporation. He was involved with Inter-Citic Minerals Inc. in 2001 as an advisor on a mining-related computer project in China. Mr. Schwartz serves as a Member of the Advisory Board at RedHill Biopharma Ltd. Mr. Schwartz has also held executive positions in various public and private companies including, among others, President, CEO and Director of Cedara Software Corp. In addition, Mr. Schwartz is the chairman of the board of Mitec. Mr. Schwartz has over 35 years of experience in launching products, R&D, international distribution agreements, re-organization in large-scale corporations, venture capital financing, and negotiating mergers and acquisitions.
Joseph Cordiano
PRINCIPAL, CITYZEN DEVELOPMENT GROUP
Joseph Cordiano joined Cityzen Development Group, a real estate development company, as a principal in 2006, where he is responsible for the sales and marketing as well as new business development of its Greater Toronto Area projects. During his 21 years of public service as a Member of the Ontario Provincial Legislature, Mr. Cordiano served as the Minister of Economic Development and Trade, GTA Regional Minister, and as a member of the Priorities and Planning Committee of Cabinet. A graduate of the University of Toronto and The University of Toledo, Ohio, Mr. Cordiano holds an MBA with a specialty in marketing.
BRIAN PEDLAR
PRESIDENT & CEO, COVALON TECHNOLOGIES LTD.
Brian Pedlar has been President and Chief Executive Officer of the Corporation since April 3, 2010 and a member of the Board since January 14, 2010. Previously, Mr. Pedlar was President of Pedlar Ventures Limited, a private venture investment and consulting firm based in Oakville, Ontario. He has served in senior executive positions with public companies including temporary Chief Financial Officer, Cygnal Technologies Corporation, October 2007; President, Cedara Software Corp., 2005 to 2006; Chief Financial Officer, Cedara Software Corp., 2004 to 2005; and Director of Finance, Cedara Software Corp., 2000 to 2004. Mr. Pedlar has also held senior executive positions with Merge Healthcare and IMAX Corporation. Mr. Pedlar holds a Bachelor of Science degree from Mount Allison University, a post-graduate diploma in Accounting from Wilfrid Laurier University, is a Canadian Chartered Public Accountant and Chartered Accountant. 
Jeffrey Mandel
PRESIDENT AND CEO, MITEC TECHNOLOGIES INC.
Jeffrey Mandel is currently President and Chief Executive Officer of Mitec Technologies Inc., formerly Mitec Telecom Inc. (MTM.h, TSXV). Mitec exited the telecom and satellite and communications area in 2012. From 2013 to 2015, Mitec was involved in development of technology that addresses certain security and privacy risks associated with electronic data transfer. Mr. Mandel has been involved in the high-tech, communications, healthcare and retail industries over his 30-year career and has led capital development activities as well as identified and executed various successful commercialization strategies for companies for which he has been active. Mr. Mandel has broad experience in corporate finance, mergers and acquisitions and investor relationship management throughout his career, having progressed through a number of senior positions at various firms in the Canadian securities industry.
Dr. Ian Brindle
PROFESSOR EMERITUS AT BROCK UNIVERSITY
Dr. Ian Brindle is currently Professor Emeritus at Brock University. Dr. Brindle is also the former Vice-President of Research, former Dean of Chemistry and has held other academic posts at Brock University since 1968. Dr. Brindle is a Professor of Chemistry, holds a Chancellor’s Chair in Research Excellence, is a fellow of the Royal Society of Chemistry (UK), and is the author of more than 100 publications in analytical chemistry. The University of Manchester awarded Dr. Brindle the degree of Doctor of Science for belonging to that group of scientists who “have distinguished themselves as authorities in the field by their substantial and original contributions to the advancement of knowledge”. He has served on a number of committees over the years, including on the Advisory Committee on Environmental Standards and as President of the Science for the Handicapped Committee of the National Science Teachers Association of America. He also holds a Bachelor of Science from Manchester University and a Masters of Science from Brock University.
Major General Gale Pollock
ARMY NURSE CORPS, CRNA, FACHE, FAAN
Before retiring from the U.S. Army in 2008, Maj. Gen. Gale Pollock served as Commander, US Army Medical Command, and Acting Surgeon General of the Army. In the latter role, she was the first woman or non-physician to hold this role in any of the military services, and managed a $9.7B annual budget. Maj. Gen. Pollock is an adjunct clinical professor of Yonsei University Graduate School of Nursing, owner of Pollock Associates, an LLC doing healthcare consulting, and serves on several scientific advisory boards. Maj. Gen. Pollock was the founding Executive Director of the Louis J. Fox Center for Vision Restoration in Pittsburgh, PA, served as an associate professor at the University of Pittsburgh School of Medicine and School of Nursing, and was an Advanced Leadership Fellow in Harvard University’s Advanced Leadership Initiative.
Dr. Myrna Francis
PRESIDENT OF MFRAN HEALTHCARE ADVISORY SERVICES
Dr. Myrna Francis is currently the President of Mfran Healthcare Advisory Services. She has an extensive background in healthcare and is well-known in both private and public sectors; her experience spans the international marketplace – Canada, the US, and Europe. She Dr. Francis has previously held positions as the President and CEO of Canada Health Infoway, Vice President, Global Healthcare Sector, at CGI Group Inc., Partner at CSC Healthcare Group, and numerous executive positions with the Ontario Ministry of Health. She has also served as a Board Director for a variety of companies and organizations, including RxCanada, Allstate Insurance Company of Canada, and Cedara Software Corp. She currently provides strategic advisory services in the public sector and to multinational private sector companies regarding health information technology, business transformation, business and product growth strategies, and innovation as an independent consultant. Dr. Francis holds a Master’s Degree in Bio-Psychology and Ph.D. in Medical Sciences, both from McMaster University, and a Multi-Party Negotiations Certification from Harvard Law School.
Ron Smith
INDEPENDENT DIRECTOR
Ron Smith (FCPA, FCA, ICD.D) is an experienced independent director with years of Board experience in the private, not-for-profit, and public sectors. He is the Chair of the Board of the Nova Scotia Public Service Superannuation Fund and of the Western Regional Enterprise Network. He also serves on the boards of Alamos Gold Inc., PROREIT, the IWK Health Centre, Ombudsman for Banking Services and Investments (OBSI), and Engage Nova Scotia. Over his remarkable career, Mr. Smith has held numerous high-profile executive positions. He served as Interim CEO of Nova Scotia Business Inc. concurrently with his work as a Director thereof. He was CFO of Nova Scotia Power and Emera prior to his retirement in 2005, and CFO of MT&T prior to the merger that created Bell Aliant. He has also served on the Board of the Canada Pension Plan Investment Board, was Chair of the Board of Governors of Acadia University from 2004 to 2009, and was the Chair of the National Board of The Arthritis Society from 2016 to 2018. Mr. Smith has the prestigious designation of Fellow of the Chartered Professional Accountants and holds the ICD.D designation from the Rotman School of Business.
John Suk
OWNER OF ALTMAX CONSULTING
Mr. John Suk is currently the owner of Altmax Consulting, a Canadian healthcare consulting company. After holding senior executive roles at McNeil Labs (Johnson & Johnson), GlaxoSmithKline plc, and Hoffman La Roche, in 1997, Mr. Suk founded Byk Canada (later known as Nycomed), a subsidiary of German company Byk Gulden. In the fourteen years Mr. Suk served as President and CEO of Nycomed, the company’s sales volume blossomed to over $300 million. From 2006 to 2017, Mr. Suk served on the Board of Directors of Brock University and was Chair of Brock’s Board of Trustees from 2013 through 2016. He has also served on the Board of Canada’s Research-Based Pharmaceutical Companies (Rx&D), a national association representing the voice of Canada’s innovative pharmaceutical industry. He has also served on the Boards of the Health Research Foundation, Innovate Niagara, IIX Technologies, Medical Futures, and Exciton Technologies. Mr. Suk holds an Advanced Management Certificate from Insead, the professional ICD.D designation from Rotman School of Management at the University of Toronto, and an H.B.Sc from Brock University.